| pubmed-article:18379830 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18379830 | lifeskim:mentions | umls-concept:C0017480 | lld:lifeskim |
| pubmed-article:18379830 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:18379830 | lifeskim:mentions | umls-concept:C1135927 | lld:lifeskim |
| pubmed-article:18379830 | lifeskim:mentions | umls-concept:C1511536 | lld:lifeskim |
| pubmed-article:18379830 | lifeskim:mentions | umls-concept:C0389545 | lld:lifeskim |
| pubmed-article:18379830 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:18379830 | pubmed:dateCreated | 2008-12-17 | lld:pubmed |
| pubmed-article:18379830 | pubmed:abstractText | In Germany the heptavalent pneumococcal conjugate vaccine (PCV7) has been recommended as a general infant vaccination since 2006. Data from similar programmes in the USA have reported a reduction of pneumococcal diseases in both vaccinated and unvaccinated populations, suggesting herd immunity effects. This study analyses the cost-effectiveness of a general vaccination with PCV7 in Germany based on these findings. | lld:pubmed |
| pubmed-article:18379830 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18379830 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18379830 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18379830 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18379830 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18379830 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18379830 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18379830 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18379830 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18379830 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:18379830 | pubmed:issn | 1618-7598 | lld:pubmed |
| pubmed-article:18379830 | pubmed:author | pubmed-author:ReinertRalf... | lld:pubmed |
| pubmed-article:18379830 | pubmed:author | pubmed-author:ClaesChristaC | lld:pubmed |
| pubmed-article:18379830 | pubmed:author | pubmed-author:von der... | lld:pubmed |
| pubmed-article:18379830 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18379830 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:18379830 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18379830 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18379830 | pubmed:pagination | 25-38 | lld:pubmed |
| pubmed-article:18379830 | pubmed:meshHeading | pubmed-meshheading:18379830... | lld:pubmed |
| pubmed-article:18379830 | pubmed:meshHeading | pubmed-meshheading:18379830... | lld:pubmed |
| pubmed-article:18379830 | pubmed:meshHeading | pubmed-meshheading:18379830... | lld:pubmed |
| pubmed-article:18379830 | pubmed:meshHeading | pubmed-meshheading:18379830... | lld:pubmed |
| pubmed-article:18379830 | pubmed:meshHeading | pubmed-meshheading:18379830... | lld:pubmed |
| pubmed-article:18379830 | pubmed:meshHeading | pubmed-meshheading:18379830... | lld:pubmed |
| pubmed-article:18379830 | pubmed:meshHeading | pubmed-meshheading:18379830... | lld:pubmed |
| pubmed-article:18379830 | pubmed:meshHeading | pubmed-meshheading:18379830... | lld:pubmed |
| pubmed-article:18379830 | pubmed:meshHeading | pubmed-meshheading:18379830... | lld:pubmed |
| pubmed-article:18379830 | pubmed:meshHeading | pubmed-meshheading:18379830... | lld:pubmed |
| pubmed-article:18379830 | pubmed:meshHeading | pubmed-meshheading:18379830... | lld:pubmed |
| pubmed-article:18379830 | pubmed:meshHeading | pubmed-meshheading:18379830... | lld:pubmed |
| pubmed-article:18379830 | pubmed:meshHeading | pubmed-meshheading:18379830... | lld:pubmed |
| pubmed-article:18379830 | pubmed:meshHeading | pubmed-meshheading:18379830... | lld:pubmed |
| pubmed-article:18379830 | pubmed:meshHeading | pubmed-meshheading:18379830... | lld:pubmed |
| pubmed-article:18379830 | pubmed:meshHeading | pubmed-meshheading:18379830... | lld:pubmed |
| pubmed-article:18379830 | pubmed:meshHeading | pubmed-meshheading:18379830... | lld:pubmed |
| pubmed-article:18379830 | pubmed:meshHeading | pubmed-meshheading:18379830... | lld:pubmed |
| pubmed-article:18379830 | pubmed:meshHeading | pubmed-meshheading:18379830... | lld:pubmed |
| pubmed-article:18379830 | pubmed:meshHeading | pubmed-meshheading:18379830... | lld:pubmed |
| pubmed-article:18379830 | pubmed:meshHeading | pubmed-meshheading:18379830... | lld:pubmed |
| pubmed-article:18379830 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:18379830 | pubmed:articleTitle | Cost effectiveness analysis of heptavalent pneumococcal conjugate vaccine in Germany considering herd immunity effects. | lld:pubmed |
| pubmed-article:18379830 | pubmed:affiliation | Centre for Health Economics and Health System Research, Leibniz University of Hannover, Hannover, Germany. cc@ivbl.uni-hannover.de | lld:pubmed |
| pubmed-article:18379830 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18379830 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18379830 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18379830 | lld:pubmed |
